Literature DB >> 22103651

Association between the PPARG gene polymorphism and the risk of diabetic nephropathy: a meta-analysis.

RuiChao Yu1, Hong Bo, SongMing Huang.   

Abstract

BACKGROUND: The Pro12Ala polymorphism in the peroxisome proliferator-activated receptor gamma (PPARG) gene is suggested to associate with diabetic nephropathy. AIM: A meta-analysis was conducted to investigate the potential association of PPARG gene polymorphisms with susceptibility to diabetic nephropathy.
METHODS: A comprehensive search of MEDLINE (1966 to June 2011) was conducted to identify published epidemiologic studies related to polymorphisms of the PPARG gene and diabetic nephropathy. A database search yielded 5 studies involving 2758 patients. Odds ratios (ORs) along with their 95% confidence intervals (CIs) were computed to compare the distribution of alleles and genotypes between cases and controls.
RESULTS: The combined results based on all studies showed no significant difference in genotype distribution (Pro/Pro: OR. 1.42, 95% CI, 0.96-2.09); Pro/Ala: OR, 0.74, 95% CI, 0.50-1.10; Ala/Ala: OR, 0.85, 95% CI, 0.52-1.38) between cases and controls. After stratification for race, results were similar except that patients with diabetic nephropathy had a significantly higher frequency of Pro/Pro (OR, 1.82; 95% CI, 1.17-2.85) than controls among Asians.
CONCLUSION: This meta-analysis suggests that the Pro12Ala polymorphism of the PPARG gene may be associated with diabetic nephropathy among Asians.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22103651     DOI: 10.1089/gtmb.2011.0242

Source DB:  PubMed          Journal:  Genet Test Mol Biomarkers        ISSN: 1945-0257


  5 in total

1.  The PPARγ2 P12A polymorphism is not associated with all-cause mortality in patients with type 2 diabetes mellitus.

Authors:  Antonio Pacilli; Sabrina Prudente; Massimiliano Copetti; Andrea Fontana; Luana Mercuri; Simonetta Bacci; Antonella Marucci; Federica Alberico; Raffaella Viti; Antonio Palena; Olga Lamacchia; Mauro Cignarelli; Salvatore De Cosmo; Vincenzo Trischitta
Journal:  Endocrine       Date:  2016-03-08       Impact factor: 3.633

2.  Role of TCF7L2 and PPARG2 Gene Polymorphisms in Renal and Cardiovascular Complications among Patients with Type 2 Diabetes: A Cohort Study.

Authors:  Bancha Satirapoj; Pamila Tasanavipas; Ouppatham Supasyndh
Journal:  Kidney Dis (Basel)       Date:  2019-03-06

3.  Network pharmacology and molecular docking technology-based predictive study of the active ingredients and potential targets of rhubarb for the treatment of diabetic nephropathy.

Authors:  Shaojie Fu; Yena Zhou; Cong Hu; Zhonggao Xu; Jie Hou
Journal:  BMC Complement Med Ther       Date:  2022-08-06

4.  The Rate of Decline of Glomerular Filtration Rate May Not Be Associated with Polymorphism of the PPARγ2 Gene in Patients with Type 1 Diabetes and Nephropathy.

Authors:  Bingmei Yang; Hongxin Zhao; Beverley Ann Millward; Andrew Glen Demaine
Journal:  PPAR Res       Date:  2014-01-22       Impact factor: 4.964

5.  Based on Network Pharmacology Tools to Investigate the Molecular Mechanism of Cordyceps sinensis on the Treatment of Diabetic Nephropathy.

Authors:  Yan Li; Lei Wang; Bojun Xu; Liangbin Zhao; Li Li; Keyang Xu; Anqi Tang; Shasha Zhou; Lu Song; Xiao Zhang; Huakui Zhan
Journal:  J Diabetes Res       Date:  2021-02-05       Impact factor: 4.011

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.